ªø©°¤j¾Ç¹Ï®ÑÀ]²°T

91¦~2¤ë18¤é                                          ²Ä¤Ü¤T´Á

 
 
¥Ø¦¸
³ü¡BµøÅ¥¤¤¤ß§ï³y¡B­«·s¶}¹õ¬ö¨Æ
¶L¡B¹Ï®ÑÀ]¶g¬¡°Ê³ø¾É

°Ñ¡B2002¦~ªº¬ì§Þ¸ê°Tºô¸ô¨t²Î

¸v¡BCINAHL¤¤ªºThe Cochrane Library¤¶²Ð

¥î¡B¢¸¢¯¦~¦^ÅU¡G¹Ï®ÑÀ]¤j¨Æ°O

¡@

¹Ï®ÑÄò­É5240°Ñ¦Ò¿Ô¸ß5622

µøÅ¥¤¤¤ß§ï³y¡B­«·s¶}¹õ¬ö¨Æ
¾ú¸g4­Ó¥b¤ëªº³¬À]¬I¤u¡AµøÅ¥¤¤¤ß©ó90¦~11¤ë19¤é­«·s¶}©ñ¨Ï¥Î¨Ã©ó91¦~1¤ë4¤é¶êº¡¶¶§QªºÁ|¿ì¤F¶}¹õ¬¡°Ê¡C¦A³y«áªºµøÅ¥¤¤¤ß¬O­Ó¬ð¯}¶Ç²Î¹Ï®ÑÀ]­·®æªº¥þ·sªÅ¶¡¡A¤£¶È¼WÁʤF³\¦hµø°T³]³Æ¡B§ó©µªø¤F¶}©ñ¨Ï¥Î®É¶¡¡C´Á«Ý¹ñ·sªºµøÅ¥¤¤¤ß±aµ¹ÅªªÌ­Ìªº¡A¤£¥u¬O¦h¤¸¤Æªº¾Ç²ß¡A§ó¯à¥R¹êºë¯«¥Í¬¡¡C
¬Û«H¦b§ï³y«e´¿¸g¨Ï¥Î¹LªºÅªªÌ­Ì­«¦^µøÅ¥¤¤¤ß®É¡A·í¹q±èªù¦b5¼Ó¶}±Òªº¨º¤@?¨º¡A²Ä¤@­Ó·Pı¬O¡G«z¡A§Ú¦³¨S¦³¨«¿ù¦a¤è°Ú!¡A¤£­nÃhºÃ³oùؽT¹ê¬Oªø©°¤j¾Ç¹Ï®ÑÀ]ªºµøÅ¥¤¤¤ß¡C
¦b®Õ¤èªº¤ä«ù¡BÀ]ªøªº­pµeª§¨ú¡B¤u³]¨t¦ã­Û¿Õ¦Ñ®vªººë¤ß³]­p¡BŪªÌªA°È²Õ¶À«ï»ö²Õªøªº²Ó¤ß³W¹º¤Î¤u°È¤G³B¦P¤¯­Ìªº¥þ¤O°t¦X¡A§Ú­Ì³Ð³y¤Fªø©°¤j¾Ç¹Ï®ÑÀ]ªº¥t¤@¶µ¯S¦â¡G¤@³B¥Rº¡²{¥N¤Æ­·®æªºµøÅ¥¤¤¤ß¡C
89¦~6¤ë°_¹Ï®ÑÀ]¶}©l¶i¦æµøÅ¥¤¤¤ß²{¦³³]³Æ¤ÎªA°È¤§ÀË°Q»P§ïµ½³W¹º¡A7¤ë°ÑÆ[¦U¤j¾Ç¹Ï®ÑÀ]ªºµøÅ¥¤¤¤ß¡A9¤ëÀ]ªø¯S§O©e½Ðªð®ÕªA°Èªº¤u³]¨t¦ã­Û¿Õ¦Ñ®v­t³dªÅ¶¡³]­p³W¹º¡C¨ä¶¡¸g¥ÑµL¼Æ¦¸ªº°Q½×·|ij¤Î¶i¦æ¤uµ{ª««~ªº½ÐÁÊ¡Bµo¥]¹Lµ{¡F§Ú­Ì²×©ó¦b90¦~6¤ë30¤é¥¿¦¡³¬À]¶i¦æ¤uµ{¡A¨ä¶¡¬°¤F¤£¼vÅT±Ð®v­Ì­É¾\±Ð¾Ç©Ò»Ý¤§µøÅ¥¸ê®Æ¡A§Ú­Ì¤´µM«ùÄò¦a´£¨Ñ³¬¬[¦¡ªº­É¾\ªA°È¡A·PÁ¦Ѯv­Ì°t¦X§Ú­Ìªº§@·~¡C

·ØµM¤@·sªºµøÅ¥¤¤¤ß°£¤F­ì¦³ªº´CÅé¥~¤]«ùÄò¦aÁʸmDVD³W®æªº´CÅé¸ê®Æ¡A¥t¥~¤@¦@³W¹º¤F¤»°Ï¡G

¡°¦h´CÅéÀH¿ï¨t²Î(MOD):´£¨Ñµ²¦X¼Æ¦ì¼v¹³¤Î¤¬°Ê¦¡ªº¸ê®Æ´CÅé¡C

  ¡°µøÅ¥ªY½à°Ï(Video):¥i¼½©ñDVD.VCD.VHS¤ÎªY½à¦³½u¹qµøÀW¹D

¡°­µ¼ÖªY½à°Ï(Audio):¥iªY½à¼s¼½¸`¥Ø¡BCD°ÛºÐ¡B¥d¦¡¿ý­µ±a¡C

¡°¹qµøªY½à°Ï(TV): 34¦T¥­­±¤j¹qµø¥ÑµøÅ¥¤¤¤ß¿ï¼½©T©wÀW¹D¡A¤£»Ý¿ì²z­É¾\§Y¥iªY½à¸`¥Ø¡C

¡°¤Û¿O¤ù°Ï(Slide):¨Ï¥Î¤Û¿O¤ù¾÷¾\ŪÀ]ÂäۿO¤ù¸ê®Æ

¡°·LÁY¸ê®Æ°Ï(Microfilm):´£¨Ñ¹L´Á´Á¥Z·LÁY¸ê®Æªº¾\Ū.½Æ¦L¤Î¤Û¿O¤ù¸ê®Æ¤§½Æ¦L

·sªºµøÅ¥¤¤¤ß¥]§t¤»¶¡¹ÎÅé©ñ¬M«Ç¤Î¥H¤W¦U°Ï¤@¦@´£¨Ñ¤F253­Ó®u¦¸ªº§¤¦ì¡A¤£½×¬O¤@¦ì¡B¤G¦ì©Î¤T  ¤­¦n¤Í©Î¾ã¯Z§Q¥ÎµøÅ¥À]Âöi¦æ±Ð¾Ç¡A§Ú­Ì³£´Á±æ¯à¾¨¶q¦aº¡¨¬ÅªªÌªº»Ý¨D¡C

      µøÅ¥¤¤¤ß¬ÛÃöªº­«­n°T®§¦³¶}À]®É¶¡ªº§ïÅÜ¡B­É¾\¤èªkªº²§°Ê..µ¥µ¥¡C»¡©ú¦p¤U¡G

¡°µøÅ¥¤¤¤ß¶}À]®É¶¡

¶g¤@~¶g¤­ 8:00~22:50¡]±ß¤W¤]¥i¥H¨Ï¥Î³á¡I¡^

¶g¤» 10:00~17:50

¶g¤é¥ðÀ]

¡°­É¾\¤èªk

                1.ŪªÌ¦Û¦æ¶i¤JµøÅ¥¸ê®Æ°Ï¡A¿ï¨ú±ýªY½à¤§¸ê®Æ¦ÜÂdÂi¾Ì¥»¤H¾Ç¥Íµý©Î¾­ûµý¿ì²zÀ]¤º¨Ï¥Î¡C

                2.¥»®Õ±M¥ô±Ð®v¥i¥H¾Ì¥»¤H¾­ûµý¿ì²z¥~­É¸ê®Æ¡A©Î©óºô­¶¤U¸ü¡u©e°U¥~­É¥Ó½Ð³æ¡v©e°U¥L¤H¥N¬°¿ì²z­É¾\¡A­É´Á¤C¤Ñ¤£¥iÄò­É¡B¥B¹O´ÁÂkÁÙ¨C¥ó¨C¤Ñ»@´Ú30¤¸¡C

·í§Ú­Ì¦³¤F¥þ·sªº³]³Æ«á¡A§ó§Æ±æ¯à«ùÄò¦a¥R¹ê¦h¼Ë¤Æ¡BÂ×´IªºµøÅ¥À]ÂáA©Ò¥H½Ð¦U³æ¦ì¡B¬ì¨t¿ãÅDªº±ÀÂ˵øÅ¥¸ê®Æ¡C¦pªG»{¬°¦³­È±oªY½àªº¸ê®Æ¡A·q½Ð±N¬ÛÃö®Ñ¥Ø¸ê®Æ´£¨Ñ¦U³æ¦ì¡B¬ì¨t­t³d¹Ï®Ñ¸ê®Æ±ÀÂˤ§¤H­û·JÁ`¡C

Åwªï«B·sª¾¤@¦P¨Ó¤À¨ÉªY½à¦n§@«~ªº§Ö¼Ö¡C

±zªº¥Î¤ß¥i¥H³y´N¥X¥Rº¡´r®®ªº¹Ï®ÑÀ]¡C

                                            (¥H¤W¥ÑµøÅ¥¤¤¤ß´£¨Ñ)

¹Ï®ÑÀ]¶gªº¦^ÅU

¬°«P¶i¤j®a¹ï¹Ï®ÑÀ]¦U¶µªA°Èªº¤F¸Ñ»P¤ä«ù¡A¥H¤Î¬°°t¦X¥»À]µøÅ¥¤¤¤ß¥H¥þ·s­±»ª­«·s¶}©ñ¡A¦]¦Ó©ó12¤ë24¤é¦Ü12¤ë28¤éÁ|¦æ¹Ï®ÑÀ]¶g¬¡°Ê¡A±À¥X¤@¨t¦C¬¡°Ê¨Ó¹ªÀyŪªÌ¦h§Q¥Î¹Ï®ÑÀ]¡C

¦p¤µ¹Ï®ÑÀ]¶g¦b¾Ç®Õ®v¥Íªº°Ñ»P¤U¤w§iµ²§ô¡A°£¨Ì©¹¨Ò¶i¦æ¡u¦³¼ú¼xµª¡v¡A¨ÃÁ|¿ì¤F±MÃDºtÁ¿¬¡°Ê¡C¥H¤U´N³o¨Ç¬¡°Ê¦¨ªG°µ¤@²³æ»¡©ú¡G

¥DÃD­«ÂI¥Ñ¨Ó¡G¦]ªñ¦~¨Ó°ê¤º¥~¹ð¦¸µo¥Í¤£¥i§Ü©Ú¤§¤Ñ¨a»P¤Hº×¡A¦pªñ´Á¤§¡u¯Ç²ú­·¨a¡v»P¡u¬ü°ê911®£©Æ§ðÀ»¨Æ¥ó¡vµ¥¡A¦A¦A¬Ò¹ï¤HÃþ¥Í¬¡¤Î¤ßÆF²£¥Í¼vÅT¡C¦]¦Ó¥H¡uÁA¸Ñ§Ú­Ì©Ò¥Í¦sªºÀô¹Ò¡F¥H¤Î·s¥@¬ö¨ÓÁ{ªº¥þ²yÄ@´º¡I¡v¬°¥»¦¸¬¡°Ê¤§¥DÃD¡C

   1.¥DÃD¯S°Ï~¼v¤ùªY½à
¦Û¶}¤ÑÅP¦a¥H¨Ó¡A¤õ¤sÃzµo¡B®ü¼S¨g´é¡B¦a¾_Â_¼hµ¥§Y¶ì³y¤F¦a²yªº­±»ª¡A¤£±o¤£Åý¤HÃþÅå³Y¤j  ¦ÛµMÅå¤Hªº¤O¶q¡C¤HÃþ¹ï¤j¦ÛµM¨a¶Hªº«Â¤Oº¥·P§ô¤âµLµ¦¡A§Ú­Ì¸Ó¦p¦ó±q¤¤¨D¦s¡I»P¤§¦@¦s¦@®e¡H¡C¦]¦Ó©ó12¤ë24¤é¦Ü12¤ë28¤é¨C¤é¤¤¤È»P±ß¤W¶i¦æ¹q¼v¼½©ñ¡A¿ï¼½Discovery¨t¦C¼v¤ù¡A»P¼öªù±j¤ù¡A¤ù¦W¤À§O¬°¡u»{Ãѯf¬r¡v¡B¡u¦a¾_¡v¡B¡u¬x¤ô¡v¡B¡uÀs±²­·¡v¡B¡u¾ðªº¼Ö³¹¡v¡F»P¡uÀb«È¥ô°È¡v¡B¡u¤õµK¤§»R¡v¡B¡u¥Ã¤£§´¨ó¡v¡B¡u¤Ñ¤H¥æ¾Ô¡v¡B¡uºñ¦â©_ÂÝ¡v¡C

2.¦³¬ÝÀÁ¦³®³~¦³¼ú¼xµª¬¡°Ê
¦¹¬¡°Ê¦V¨Ó¬O³Ì¨üŪªÌÅwªïªº¡A¤µ¦~µªÃD«D±`¬O¿ãÅD¡A15²ÕÃD¥Ø´X¥G©ó3¤Ñ¤º§Y¬°ÅªªÌ·mµª§¹¦¨¡Aµª¹ïªÌ¦U±o¶L¨Õ¤¸¹Ï®Ñ§¨é¡C

3.¦^õX¥DÅU«È- Top 5­É®Ñ¤H¼ú¹{¼ú¬¡°Ê
·PÁ¹ϮÑÀ]¦Ñ¥DÅUªº·R¥Î»P¤ä«ù¡A¤½§G­É¾\¦¸¼Æ«e¤­¦W¦W³æ¡AÃØ°e90¦~«×¤j¾Ç³¡¾Ç¥Í¹Ï®Ñ­É¾\¦¸¼Æ³Ì°ª«e¤­¦W¶L¨Õ¤¸¹Ï®Ñ§¨é¥H¯÷¹ªÀy¡A¨Ã¦P®É§Æ±æ«B·sª¾¤µ«á¯àµ¹¤©¹Ï®ÑÀ]§ó¨Îªº¤¬°Ê¡A¦@¦P¾Ç²ß¡B¦¨ªø¡C

±o¼ú¦W³æ¦p¤U¡A®¥³ß³o¨Ç¦P¾Ç¡G

±ZÄP³Ç¡]¤¤Âå¨t¡A302¥U¡^¡B³¯Ù¡¬Ã¡]Å@²z¨t¡A277¥U¡^¡B§d°ê·½¡]ª«ªv¨t¡A226¥U¡^¡B±i¯Â¸Û¡]Âå¾Ç¨t¡A220¥U¡^¡B¶À?²M¡]ÂåºÞ¨t¡A219¥U¡^

4.³Ì¨üÅwªïªº¸ê®Æ®ü³ø
¤½§G³Q­É¾\¦¸¼Æ³Ì°ª¤§¹Ï®Ñ¤ÎµøÅ¥¸ê®Æ¡A¨ä¤¤³Ì¨üÅwªïªº¸ê®Æ¤À§O¬O¡G

¤¤¤å¹Ï®Ñ«D800(¤å¾Ç)Ãþ
¡@
·s½sGUYTON
¡@
¤¤¤å¹Ï®Ñ800Ãþ
¡@
¤jÂå°|¤pÂå¥Í
¦è¤å¹Ï®Ñ
¡@
Grant¡¦s atlas of anatomy
¡@
µøÅ¥¸ê®Æ
¡@
Crossroads Caf'e
¡@
5..±MÃDºtÁ¿~³Ð¶Ë«áÀ£¤O¯g»P¤ßÆF­««Ø
12¤ë26¤éÁܽЮç¶éºa¥ÁÂå°|ºë¯«¬ì¥D¥ô±iµnµÓÂå®v¨ì¹Ï®ÑÀ]¶i¦æºtÁ¿¡AÁ¿ÃD¬°¡u³Ð¶Ë«áÀ£¤O¯g»P¤ßÆF­««Ø¡v¡C
ºtÁ¿¤¤¤À§O»¡©ú¦ó¿×À£¤O-¡u³y¦¨­ÓÅé»{ª¾¨ì¤ß²z¨­Å骺§ïÅܪº¤º¦b©Î¥~¦b¦]¯À¡C¡v¡F¦ó¿×³Ð¶Ë-¡u¸gÅç¡B¥ØÀ»¡B³Q­¢­±¹ï¤@©Î¦hºØ¨Æ¥ó¡A¦¹¨Æ¥ó²o¯A¨ì¹ê»Úµo¥Í©Î¥¼µo¥Í¡A¦ýºc¦¨«Â¯Ùªº¦º¤`©Î¨­Å駹¾ã©Ê¡C¡v¡A¨Ã·|¦]¦~ÄÖ¼h»P©Ò³BÀô¹Òµ¥¦]¯Àªº¤£¦P¡A¦Ó¼vÅT¨ä¦æ¬°¯gª¬©M³B¸m¤è¦¡¡C¦]¦¹¡A´L­«¡B±µ¯Ç¡B¥]®e¡B¹ªÀy¡B»PªÀ·|¨}¦nªº¤¬°Ê³sôµ¥¡A¬OÀ°§U³Ð¶Ë´_­ìªº¥D­nÃöÁä¡C¥»¦¸ºtÁ¿¦@­p20¤H°Ñ¥[¡C
ÁÂÁÂ¥þ®Õ®v¥Í°Ñ»P¥»¦¸¹Ï®ÑÀ]¶g¬¡°Ê¡A§Æ±æ©¹«á¹ï¹Ï®ÑÀ]Á|¿ì¤§¦U¶µ¬¡¬Ò¯àµ¹¤©¤ä«ù»P¹ªÀy¡C
2002¦~ªº¬ì§Þ¸ê°Tºô¸ô¨t²Î

¥Ñ°ê¬ì·|¬ì¾Ç§Þ³N¸ê®Æ¤¤¤ß©Ò«Ø¥ß¤§¡u¬ì§Þ¸ê°Tºô¸ô¡v¨t²Î©ó¤µ¦~«×¦A«×§ïª©¡A¥»¦¸§ïª©³Ì¤jªº§ïÅܬ°±N¥Ñ¸Ó¤¤¤ß©Ò¦Û«Ø°ê¤º¸ê®Æ®w¥Ñ»Ý±b¸¹±K½X§ï¬°§K¶O´£¨ÑÀ˯Á¡A°ê¥~¸ê®Æ®w¤´ºû«ù»Ý¿é¤J±b¸¹¤Î±K½X¡C¥H¤U´N¸Ó¨t²Î¥Ø«e¥]§tªº¸ê®Æ®w¤Î­È±o¨Ñ®Õ¤ºÅªªÌ°Ñ¦Òªº³¡¥÷°µ»¡©ú¡C

¤@¡Bºô§}¡Ghttp://sticnet.stic.gov.tw/

¤G¡B¸ê®Æ®w§t»\¤º®e¡G

¸ê®Æ®w§t»\¬ã¨s­pµe¡B´Á¥Z½×¤åºK­n¡B¾Ç³N·|ij½×¤åºK­n¡B°ê¬ì·|¸É§U¥X®u°ê»Ú·|ij½×¤åºK­n¡B³Õ¤h½×¤åºK­nº[ºÓ¤h½×¤å¯Á¤Þ¡B¬ì§Þ²°T¸ê®Æ®w¡B¬ì§Þµo®i¬Fµ¦³ø¾É¸ê®Æ®w¡B¤u·~§Þ³N¬ã¨s°|§Þ³N³ø§iºK­n¡B­¹«~¤u·~¬ã¨s©Ò§Þ³N³ø§iºK­n¡B´Á¥ZÁp¦X¥Ø¿ý(¦è¤å´Á¥Z¡B¤¤¤å´Á¥Z¡B¤j³°´Á¥Z¡B¥þ°ê¦è¤å¬ì§Þ¹Ï®Ñ)¡BBIOLOGICAL SCIENCES¡BCOMPENDEX¡BINSPEC¡BNTIS¡BSCIENTIFIC MEETINGS¡E

¤T¡B¥Ø«eÁͶÕ

1¡B¥Ø«e¥¼¦³¨ú¥Nªº°ê¤º¸ê®Æ®w¦³¾Ç³N·|ij½×¤åºK­n¡B°ê¬ì·|¸É§U¥X®u°ê»Ú·|ij½×¤åºK­n¡B¬ì§Þ²°T¸ê®Æ®w¡B¬ì§Þµo®i¬Fµ¦³ø¾É¸ê®Æ®w¡B¥þ°ê´Á¥ZÁp¦X¥Ø¿ý¡F°ê¥~¸ê®Æ®w³¡¥÷INSPEC¡BNTIS¡BScientific meetings¡A¥iÀ±¸É®Õ¤º¸ê®Æ®w¤§¤£¨¬¡C

2¡B­ì¥»¸Ó¨t²Î¤¤¯S¦³ªº°ê¤º¬ã¨s­pµe¥Ø«e¦b¬ì¸ê¤¤¤ß¤U¦³¥t¤@­Óºô¯¸¡u¬F©²¬ã¨s¸ê°T¨t²Î¡v¤]´£¨Ñ¬Û¦Pªº¸ê®Æ¡A³¡¥÷¨Ã´£¨Ñ¤F¥þ¤å¡A´N¸ê®Æ·s¿o©Ê»P«K§Q©Ê¨Ó»¡¤]¸û°ª¡A©Ò¥H«ØijŪªÌ§ï¥Ñ³o­Ó¦a¤è¬d¸ß°ê¤º¨ü¬F©²¸É§U¤§¬ã¨s­pµe¡C

3¡B³Õ¤h½×¤åºK­nº[ºÓ¤h½×¤å¯Á¤Þ¡G¦¹³B©Ò¦¬ªº³ÕºÓ¤h½×¤å¬°¸g¹L§@ªÌ±ÂÅv¥i¥Ñ¬ì¸ê¤¤¤ß´£¨Ñ¥þ¤å¤§³ÕºÓ¤h½×¤å¡A¦b¦¬¿ýªº§¹¾ã©Ê¨Ó»¡¤£¦p°ê®a¹Ï®ÑÀ]©Ò¦¬ªº§¹¾ã¡A¦ý¥þ¤å´£¨Ñ¯à¤O°ª©ó°ê®a¹Ï®ÑÀ]¡C

4¡B¤u·~§Þ³N¬ã¨s°|§Þ³N³ø§iºK­n¤Î­¹«~¤u·~¬ã¨s©Ò§Þ³N³ø§iºK­n¥¼¦A§ó·s¡A¥Ø«e¶È¦b¤u¬ã°|ºô¯¸¤W(http://itisweb.itis.org.tw/websql.dir/app/tec/tecfmo.hts)¥i¬d±o«ùÄò§ó·sªº§Þ³N³ø§i¡C

CINAHL¤¤ªºCochrane library

±`À˯ÁCINAHLªºÅªªÌ¤@©w·|µo²{±q2001¦~¶}©l¸ê®Æ®w¦h¤F¥H¤Uªº®Ñ¥Ø¸ê®Æ±Ô­z¡G

The Cochrane Library (Oxford) ** 2001 issue 2 (15 p) (7 ref 3 bib) (Update Software, online or CD-ROM, updated quarterly)

³o¼Ëªº¸ê®Æ­n¥h¨ºùاä¥þ¤å¡H

¥H¤U´NCochrane Libraryªº¸ê®Æ°µÂ²¤¶

   ¤@¡B¤º®e¡G

        1¡BThe Cochrane Library¬°¤@­Ó¹êÃÒÂå¾Ç¸ê®Æ®w¡A»s§@³æ¦ì¬°The Cochrane Collaboration¡C

        2¡B¨ä¤U¤S¤À¬°Cochrane Database of Systematic Reviews(CDSR)¡BDatabase of Abstracts of Reviews of Effectiveness(DARE)¡BThe Cochrane Controlled Trials Register(CCTR)¡BThe Cochrane Methodology Register¡BThe NHS Economic Evaluation Database¡BHealth Technology Assessment Database¡BCochrane Database of Methodology Reviews (CDMR)

¤G¡BÀ˯Á³~®|¡G¦³Ãö¨äÀ˯Á³~®|°£¥i¥H¦Û¦æ½u¤W­qÁÊ¥~¡A¥Ø«eOvid¨t²Î¤]´£¨Ñ¥úºÐª©ªº¸ê®ÆÀ˯Á¡A¦Ó°ê¤º¤]¦³¬Y¨Ç¹Ï®ÑÀ]¤Þ¶i(ŪªÌ¥i³z¹Lªø©°ªL¤f¹Ï®ÑÀ]¤Î°ê®a½Ã¥Í¬ã¨s°|HintÀ˯Á)¡C

¤T¡B¸ê®Æ©Ê½è¡G¤º®e¬O¥Ñ±M·~¹ÎÅé©Î°ê»Ú²Õ´¹ï©ó¥@¬É¤W½Ñ¦h¤åÄm¶i¦æ¨t²Î©Êªº¤åÄm¦^ÅU¡]systematic reviews¡^»Pºî¦X¤ÀªR¡]meta-analysis¡^¡A¥[¥H°Ï§OÃÒ¾Úµ¥¯Å¡A³Ì«á·J¾ãµoªí(ªô«Ø¾±¡B¶À¬f«C¡B§õ¤Í±M¡GÃÒ¾ÚÂå¾Ç²¤¶·í¥NÂå¾Ç 2001; 28; 570-73)¡A¥Ñ©ó¨ä¸ê®Æ¦³³oºØÄÝ©Ê©Ò¥HŪªÌ¦bÀ˯Á®É·|µo²{¤U¦C³oºØ±¡ªp¡G¦P¤@µ§®Ñ¥Ø¦pVaccines for preventing influenza in people with asthma¦bMedline¤¤¦³¨âµ§¡A®Ñ¥Ø¸ê®Æ´X¥G§¹¥þ¬Û¦P

1¡BAuthor¡GCates CJ. Jefferson TO. Bara AI. Rowe BH.

  Title¡GVaccines for preventing influenza in people with asthma.

  Source¡G(Cochrane Review). [update of Cochrane Database Syst Rev. 2000;(2):CD000364].[Review] [40 refs] Cochrane Database of Systematic Reviews [computer file]. (4):CD000364, 2000.

2¡BAuthor¡GCates CJ. Jefferson TO. Bara AI. Rowe BH.

  Title¡GVaccines for preventing influenza in people with asthma.

  Source¡G[update in Cochrane Database Syst Rev. 2000;(4):CD000364]. [Review] [11 refs] Cochrane Database of Systematic Reviews[computer file]. (2):CD000364, 2000.

³o¬O¦]¥»¸ê®Æ®w¯S©Ê¬°¨t²Î©Ê¤åÄm¦^ÅU¡A©Ò¥H¦³·sªº¤åÄm¥X²{¸gCochraneªº½s¿è»{¬°­È±o¥[¤J´N·|¦A¥h¼W­×­ì¨Ó¤wµoªíªº¤å³¹¡AŪªÌ¦b¬Ý¨ì³o¼Ëªº®Ñ¥Ø¸ê®Æ¥u­n¬Ý¸û·s¤@µ§§Y¥i¡C

¥|¡B®Ñ¥Øª`·N¨Æ¶µ

¥Ø«e¦bMedline¤ÎCinahl¤¤¬Ý¨ìªº®Ñ¥Øµù¿ý¤è¦¡¨Ã¤£¬Û¦P¡A¦bMedline¤¤¬O¥HCochrane Database of Systematic Reviews(CDSR)¡BDatabase of Abstracts of Reviews of Effectiveness(DARE)¡BThe Cochrane Controlled Trials Register(CCTR)­Ó§O¸ê®Æ®wµù¿ý¡A¦Ó¦bCinahl¤¤«h¥Hthe Cochrane Library°µµù¿ý¡C

¤­¡B¶i¤@¨B¾\Ū¡GNHS Centre for Reviews and Dissemination's. Cochrane Library Training page 

http://www.york.ac.uk/inst/crd/cochlib.htm.

¹Ï®ÑÀ]¤j¨Æ°O


1¤ë
¹Ï®ÑÀ]¦Û°Ê¤Æ¨t²Î¤É¯Å
2¤ë
ÂX¥R­ì¦³¡u³B²z¤¤¹Ï®Ñ¹w­ÉªA°È¡v¡AÂX®i¤F¥i­É½d³ò¨ì¡u³Ì·s¨ìÀ]¸ê®Æ¡v¡B¡uÂಾ½s¥Ø¡v¤Î¡u½s¥Ø¤¤¡vµ¥
3¤ë
¤j¤G¦P¾Ç°Ñ¥[¤¤µØ¥Á°ê´Á¥Z½×¤å¯Á¤Þ§Q¥Î«ü¾É½Òµ{
·s®Ñ³q³øºô¸ô¤Æ¡A¥iª½±µ©ó¹Ï®ÑÀ]­º­¶¬d¬Ý¦U´Á·s®Ñ²M³æ
¸Õ¿ì²Ä¤@¦¸¾Ç¥Íª½±µ¦V¹Ï®ÑÀ]¤¶ÁʹϮÑ
¡uŪªÌº¡·N«×½Õ¬d¡v³ø§i§e®Ö§¹¦¨¨Ã¤½§i©ó¹Ï®ÑÀ]­º­¶
4¤ë
¶}©ñ®Õ¤Í­É®ÑªA°È
Á|¿ì¹Ï®ÑÀ]®Õ¼y¶g¬¡°Ê
5¤ë
¥l¶}¤K¤Q¤E¾Ç¦~«×²Ä¤G¦¸¹Ï®Ñ¿Ô¸ß©e­û·|·|ij
7¤ë
·sÀ]­û¯d·ëÁâ¤W¯Z
¥¿¦¡±Ò¥ÎElsevier ScienceDirect OnSite (SDOS) 1200 ºØ¥þ¤å¹q¤l´Á¥Z
¥»À]»P¥xÆW¤j¾Ç¹Ï®ÑÀ]ñ­q¹Ï®Ñ¤¬­É¨óij
¹O´Á³qª¾ªºµo©ñ¥Ñ­ì¥ý¹O´Á¤T¤Ñ§ï¬°¹O´Á¹j¤Ñ§Y±Hµo³qª¾³æ¡A¨Ã³]©w¡uÁٮѼe­­´Á¡v¨â¤Ñ¡A¤Z¦b¼e­­´Á¤ºÂkÁٹϮѪ̧Y¥i§K°£»@´Ú
9¤ë
©µªø¤j¾Ç³¡¾Ç¥Í­É´Á¡]­ì­É´Á14¤Ñ©µªø¬°21¤Ñ¡^
¡u¥þ¤å¹q¤l´Á¥Z¨t²Î¡v±Ò¥Î¡A´£¨Ñ¶W¹L 3,500 ºØ¥þ¤å¹q¤l´Á¥Z
Á|¦æ¹Ï®ÑÀ]¤j¤@·s¥Í¾ÉÄý¬¡°Ê
¸ê°T¤¤¤ß§¹¦¨¬[³]ADSL±M½u¡A¨Ï¥Î¹Ï®ÑÀ]¹q¤l¸ê®Æ¬Ò¶·³]©w¥N²z¥D¾÷
10¤ë
¥l¶}¤E¤Q¾Ç¦~«×²Ä¤@¦¸¹Ï®Ñ¿Ô¸ß©e­û·|·|ij
11¤ë
µøÅ¥¤¤¤ß©ó§ïµ½«á­«·s¶}©ñ¨Ï¥Î¡A¶}©ñ®É¶¡¬°¶g¤@¦Ü¶g¤­8:00~22:50¡A¶g¤»10:00-17:50
¹Ï®ÑÀ]¶}©ñ®É¶¡©µªø¬°¶g¤@¦Ü¶g¤­8:00~22:50¡A¶g¤»¦Ü¶g¤é10:00-17:50
»P«n¨È¬ì§Þñ¸p¹Ï®ÑªA°È¨óij®Ñ¡A´£¨Ñ«n¨È¬ì§Þ­û¤u¾Ì¥ø·~­É®ÑÃҦܥ»À]­É®Ñ
12¤ë
Á|¦æ¹Ï®ÑÀ]¶g¬¡°Ê